Brookfield Corp’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-219,827
Closed -$2.73M 632
2022
Q3
$2.73M Buy
+219,827
New +$3.84M 0.01% 390
2022
Q2
Sell
-59,303
Closed -$1.55M 638
2022
Q1
$1.55M Buy
+59,303
New +$1.58M 0.01% 434
2021
Q2
Sell
-136,208
Closed -$4.01M 566
2021
Q1
$4.01M Sell
136,208
-18,294
-12% -$563K 0.02% 199
2020
Q4
$4.74M Buy
154,502
+75,308
+95% +$2.3M 0.02% 164
2020
Q3
$2.21M Sell
79,194
-10,249
-11% -$260K 0.01% 230
2020
Q2
$1.92M Buy
+89,443
New +$1.98M 0.01% 223

Other funds holding ELAN

Brookfield Corp's ELAN Position: Q4 2022 in Review

Brookfield Corp sold out of Elanco Animal Health (ELAN) in Q4 2022, closing a stake of 219,827 shares — an estimated $2.73M sold.

Brookfield Corp first reported a position in ELAN in Q2 2020 and held it in 6 quarters. The position peaked at $4.74M in Q4 2020. 404 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Brookfield Corp reported no remaining Elanco Animal Health position as of Q4 2022 after selling out during the quarter.
  • Brookfield Corp sold 219,827 Elanco Animal Health shares in Q4 2022, an estimated $2.73M.
  • Brookfield Corp first reported a position in Elanco Animal Health in Q2 2020 and held it in 6 quarters.
  • Brookfield Corp's Elanco Animal Health position peaked at $4.74M in Q4 2020.
  • 404 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.